SynthesisFrontiers in oncology2023

Efficacy and safety of olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis of randomized controlled trials.

Zhanyang Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.